SUBSEQUENT EVENTS	9 Months Ended
Sep. 30, 2018
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	12. SUBSEQUENT EVENTS The Company has evaluated events and transactions that occurred from September 30, 2018 through the date of the filing for possible disclosure and recognition in the financial statements. Subsequent to September 30, 2018, the Company borrowed a total of $59,500 from a related party. The Note bears interest at 10% and is due in twelve months. On October 2, 2018, the Company signed an agreement to collaborate with a clinical provider, Under the agreement, the clinical provider may assist with the Company’s recently initiated exploratory and adaptive multicenter clinical study of BTI 320 in Type 2 diabetes patients.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration